cis-Docosa-4,7,10,13,16,19-hexaenoic acid
Product Specifications
CAS Number:
6217-54-5
MDL Number:
MFCD00065722
Product Code:
ID:
A29082
Purity:
98%
Packaging:
| Product Number | A29082 |
| Name | cis-Docosa-4,7,10,13,16,19-hexaenoic acid |
| CAS | 6217-54-5 |
| MDL | MFCD00065722 |
| Purity | 98% |
| Concentration | |
| Packaging | |
| M.F | C22H32O2 |
| M.W | 328.496 |
| Storage | Freeze, sealed |
| Appearance | |
| Melting Point | |
| Boiling Point | |
| Density | |
| Flash Point | |
| Water Solubility | |
| Evapouration rate | |
| Vapour pressure | |
| Vapor Density | |
| Decomposition temperature | |
| Viscosity | |
| Sensitivity | |
| Explosive properties | |
| Oxidizing properties | |
| Incompatibilities | |
| Odour | |
| Odour Threshold | |
| SMILES | |
| InChICode | |
| InChIKey |
| GHS Symble | |
| Warning Words | |
| H-Code | |
| P-Code | |
| EINECS | |
| Hazard Codes(Europe) | |
| EU_Hazard_Risk_Phrases | |
| EU_Hazard_Safety_Phrases | |
| UN Number | |
| Transport hazard class(es) | |
| Packaging group |
| Acute Toxicity | |
| Skin corrosion/irritation | |
| Serious eye Damage/irritation | |
| Respiratory or skin sensitisation | |
| Germ Cell mutagenicity | |
| Carcinogenicity | |
| Reproductive toxicity | |
| STOT-single exposure | |
| STOT-repeated exposure | |
| Aspiration hazard |
| Purpose |
Related Products
![8-ETHYL-5,8-DIHYDRO-5-OXO-2-[1-PIPERAZINYL]PYRIDO[2,3-D]-PYRIMIDINE-6-CARBOXYLIC ACID](https://ouhetech.com/wp-content/uploads/2026/06/A28197.png)
8-ETHYL-5,8-DIHYDRO-5-OXO-2-[1-PIPERAZINYL]PYRIDO[2,3-D]-PYRIMIDINE-6-CARBOXYLIC ACID
![sodium:(2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate](https://ouhetech.com/wp-content/uploads/2026/06/A29326.png)
sodium:(2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
